Plastic surgery as the specialty of reconstruction has evolved from a merely technical discipline of reconstruction into a conceptional one that strives for tissue conservation, regeneration and optimization of healing at all steps of patient care.

In this issue four articles will cornerstone the spectrum of methodological and technical possibilities that are available in this sense. Noteworthy that the journal of *Innovative Surgical Science* has provided its unique interdisciplinary open access platform to present this progress in plastic surgery to a wider readership.

The paper by Harati and Lehnhardt from The University Hospital in Bochum, Germany, an internationally renowned limb oncology institution, addresses the changing paradigm in surgical resection of soft tissue sarcomas. While the old dogma of surgical oncology aimed at a maximum of radicality recent studies shed light on the prognostic significance of surgical margins. It is unquestioned that locally advanced soft tissue sarcoma can lead to significant functional morbidity and local recurrences despite surgical resection. Thirty percent of all patients develop distant metastases with a median overall survival of less than 15 months.

In localized disease, the most chosen treatment is still the surgical resection with negative margins. However, large retrospective analyses of the recent years could not establish a strong association between radical resections and improved local control or survival. Therefore previous radical concepts in soft tissue sarcoma surgery have been gradually replaced by more moderate approaches with function and limb-sparing resections combined with radiotherapy. At present only the quality of surgical margins and not the extent of negative margins seem to correlate with survival. This article reviews critically the literature focusing on the changing role of surgical margins in STS surgery and nicely shows the modern concept of tissue conservation in plastic surgical oncology.

Nicco Krezdorn and the Boston composite allotransplantation group directed by Bohdan Pomahac review how pathophysiological mechanisms occuring during ischemia and subsequent reperfusion cause damage to tissues procured for transplantation and also affect longterm allograft function and survival. This principle applies to autologous tissue transplantation such as free flap transfer as well as replantation. Still inadvertent tissue loss from simple skin grafts to complex flaps creates an enormous burden to patients, surgeons and to the health system.

While in the pioneering years of reconstructive microsurgery the issue of ischemia and reperfusion was addressed profoundly and widely this topic seems to have almost disappeared from the scene in favor of studies on other biological phenomena such as regeneration and cell transplantation. However, prevention of adverse outcomes by tissue preservation of tissue and organs may have a significant impact on a more complication free outcome of tissue reconstruction. The authors give a very detailed overview of the current body of knowledge of organ and tissue preservation, hopefully re-stimulating the interest and focus on this interesting area of applied physiology.

When specialized human body tissue is not available the discipline of tissue engineering is engaged in generating human tissue *ex vivo* for transplantation with the promise to either reduce donor site morbidity or provide the amount or qualities not sufficiently present in a human individual. Jeroen Vranckx and Margot Den Hondt review the history of tissue engineering as an innovative and promising field of the mid-1980s and provide the accepted body of knowledge on the biological manipulation of cells in the *ex-vivo* environment and how customized constructs for tissue regeneration can be induced. It becomes clear how much tissue engineering is opening plastic surgery to other branches of science. Thereby the scientific methods of biomaterial engineering and molecular biology meet clinical reconstruction. This opens completely new perspectives for patient care, in that the plastic surgeon will be able to solve future problems by the combined efforts of scientists, engineers, and clinicians. The expansion of the clinical reconstructive armamentarium would provide new options for wound repair, poor tissue vascularization, poor tissue match or donor site paucities. Despite the enormous potential the clinical implementation of tissue engineering is still modest mainly due to the intrinsic complexity of human tissues. It is hoped that the interest in its fascinating possibilities will prevail despite some frustration during the past epoch.

The last paper deals with the scar problem. Despite huge progress in surgery scars still create significant morbidity after trauma, tumor therapy and medical interventions, in particular in the presence of patient intrinsic factors.

The stigma of scars is driving plastic surgeons to find solutions that significantly improve patient's appearance and function. The first line therapy is based on conservative measures and may in many instances improve the clinical and functional appearance. In case of failing conservative measures a stepwise approach employing increasing levels of surgical techniques will be employed. The most powerful tool in plastic and reconstructive surgery is free microvascular tissue transfer enabling the reconstitution of major areas in one step supplying the best tissue quality and tissue match. The article by Vogt and co-authors describes the indications and provides an algorithmic approach to this special surgical approach that can solve significant scar problems.
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